UNH

Stock Market Selloff: All 11 sectors of the stock market experienced a significant decline following President Trump's announcement of new tariff plans.

Impact on Financial Institutions: Banks and private-equity firms were particularly affected, as investors are concerned about potential recession impacts leading to reduced borrowing and dealmaking activities.

Fastest News Alerts: Benzinga Pro offers real-time intelligence and alerts for traders to stay updated on stock market movements.

Exclusive Community: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories from Benzinga reporters.

Dr. Mehmet Oz's Confirmation: The U.S. Senate confirmed Dr. Mehmet Oz as the head of the Centers for Medicare & Medicaid Services (CMS) in a 53-45 party-line vote, amidst significant funding cuts proposed by the Trump administration.

Challenges Ahead for CMS: Dr. Oz will lead CMS during a period of potential job cuts and funding reductions, particularly to the Medicaid program, while he has not opposed these cuts, emphasizing the need for the program to remain viable.

Market Reaction to Tariffs: Following President Trump's new tariffs, the stock market experienced a significant decline, with major indices like the Dow and S&P 500 dropping nearly 4% and 4.8%, respectively. Jim Cramer suggests focusing on domestic companies with pricing power that can withstand economic slowdowns.

Investment Recommendations: Cramer highlights sectors such as pharmaceuticals, utilities, and telecommunications as promising for investors in the current climate, recommending specific companies like Cardinal Health and Duke Energy, while also noting potential gains for defense contractors due to tariff-related orders.

Market Resilience: Companies like Lamb Weston, Verizon, AbbVie, and TJX showed resilience during a significant market selloff, as investors sought stocks in tariff-resistant sectors such as food and pharmaceuticals.

Impact of Tariffs: The Dow Jones Industrial Average experienced a sharp decline of about 1,300 points, highlighting the market's reaction to anticipated tariffs and leading investors towards discount retailers.

DOJ Fraud Lawsuit Against UnitedHealth: The U.S. Department of Justice is pushing a federal judge to continue a fraud lawsuit against UnitedHealth, alleging the company overbilled Medicare by at least $2.1 billion due to unsupported diagnosis codes.

Case Background and Timeline: Initially filed by whistleblower Benjamin Poehling over a decade ago, the case was taken over by the DOJ in 2017, with UnitedHealth expected to respond to the allegations by May 2.

Investment Strategies for Dividend Stocks: Many investors seek dividend-focused stocks and funds to generate passive income for retirement or personal expenses, with suggestions including the Schwab U.S. Dividend Equity ETF (SCHD) and high-yield stocks like Verizon and AT&T.

Reddit User's Investment Inquiry: A Reddit user is looking for advice on long-term dividend stocks to grow a $30,000 investment over 20 years, aiming for stability and sufficient returns to cover annual vacations, receiving various recommendations from the community.

FTC Complaint Against PBMs: The Federal Trade Commission has filed a complaint against CVS Health, Cigna, and UnitedHealth for allegedly inflating insulin prices through unfair practices, benefiting financially from drug rebates while patients face higher costs.

Legal Challenges and Stay Order: The FTC's proceedings are currently paused due to an administrative stay, with ongoing legal challenges from competing pharmacy benefit managers regarding the FTC's authority and potential disruptions to existing drug rebate contracts.

Investigation of UnitedHealth Group: Rosen Law Firm is investigating potential breaches of fiduciary duties by UnitedHealth Group's directors and officers related to a Department of Justice investigation into the company's billing practices.

Investor Support and Legal Expertise: The firm encourages investors to seek qualified legal counsel with a proven track record in securities class actions, highlighting their own success in recovering significant settlements for investors.

FTC Lawsuit on Hold: The Federal Trade Commission has paused its lawsuit against major pharmacy-benefit managers regarding insulin prices due to the firing of two commissioners by President Trump.

Recusal of Commissioners: With only two remaining Republican commissioners recused from the case, the FTC lacks the necessary oversight to proceed with the litigation.

Kinsale Capital Group Performance: Joshua Brown highlighted Kinsale Capital Group's strong performance, with a Buy rating maintained by Truist Securities and an increased price target of $525. The stock closed at $488.15, gaining 0.3%.

Earnings Expectations for PG&E and UnitedHealth: PG&E is set to report earnings on April 24, with expectations of a rise in quarterly earnings to 40 cents per share, while UnitedHealth will release its results on April 17, anticipated to show earnings of $7.31 per share.

FTC Enforcement Action Paused: The FTC has temporarily halted its enforcement action against pharmacy benefit managers (PBMs) accused of using a rebate scheme that increased insulin prices, due to insufficient commissioners available to adjudicate the case.

Commissioner Recusal and Stay Duration: The stay will last for at least 105 days, following the recusal of Chairman Andrew Ferguson and Commissioner Melissa Holyoak from the proceedings.

Death Penalty Announcement: Attorney General Pam Bondi announced that federal prosecutors will seek the death penalty for Luigi Mangione, accused of the politically motivated assassination of UnitedHealthcare executive Brian Thompson, emphasizing a commitment to restoring capital punishment.

Policy Shift on Capital Punishment: The U.S. Attorney General's office has revived the federal death penalty, directing prosecutors to pursue it in specific cases, including violent crimes, while also reviewing past decisions not to seek it, reflecting a tough-on-crime stance by the administration.

Death Penalty Case: The Department of Justice intends to pursue the death penalty for Luigi Mangione, accused of murdering Brian Thompson, the CEO of UnitedHealthcare.

Market Insights: Julie Hyman provides updates on market actions and expert analysis related to wealth management.

Death Penalty Sought: Attorney General Pam Bondi has directed federal prosecutors to seek the death penalty for Luigi Mangione, charged with the murder of UnitedHealthcare CEO Brian Thompson in New York City, describing it as a premeditated assassination.

Political Violence: The Department of Justice characterized Thompson's murder as an act of political violence, highlighting the planning involved and the potential risk to bystanders during the crime.

Market Decline: Major U.S. stock indexes, including the S&P 500 and Nasdaq 100, experienced significant declines due to concerns over President Trump's new tariffs, which are expected to negatively impact economic growth and corporate earnings.

Labor Market and Economic Indicators: While initial unemployment claims fell unexpectedly, continuing claims rose to a multi-year high, indicating challenges in workforce reentry; additionally, the ISM services index dropped to a nine-month low, reflecting weakening economic conditions.

Company Overview and Earnings Expectations: UnitedHealth Group, with a market cap of $494.3 billion, is set to announce its Q1 2025 earnings on April 17, expecting a profit of $7.27 per share, up from $6.91 in the previous year. Analysts project a fiscal 2025 EPS of $29.63, reflecting a 7.1% increase from fiscal 2024.

Stock Performance and Analyst Ratings: Despite recent challenges, including a drop in shares due to revenue shortfalls and regulatory scrutiny, UNH has outperformed broader markets over the past year, with a 17.6% increase. Analysts maintain a "Strong Buy" consensus rating, with an average price target suggesting a potential upside of 17.5%.

Research Reports on Major Stocks: The Zacks Research Daily highlights new reports on 16 significant stocks, including Broadcom, UnitedHealth, and Toyota, emphasizing their performance, growth potential, and challenges in the current market environment.

Market Insights and Trends: The article discusses pre-market trends influenced by economic releases, with a focus on how companies like Broadcom and UnitedHealth are navigating strong demand and high costs, while also addressing concerns such as declining membership and rising debt levels.

Market Decline: Major US stock indexes, including the S&P 500 and Nasdaq 100, fell sharply due to escalating trade tensions after China announced a 34% tariff on all US imports, pushing the S&P 500 to an 11-month low and raising concerns about potential recession impacts on the economy.

Economic Indicators: Despite a stronger-than-expected rise in March nonfarm payrolls, the unemployment rate increased slightly, and average hourly earnings growth was weaker than anticipated, contributing to a risk-off sentiment in the markets and a flight to safety into government bonds.

Johnson & Johnson Performance: Johnson & Johnson is the worst performing component of the Dow today, down 4.2%, but has a year-to-date gain of 9.8%.

Other Dow Components: Boeing is also down by 1.5%, while UnitedHealth Group has seen a slight increase of 0.6% on the day.